Immunovant, Inc. (IMVT) vs Kodiak Sciences Inc. (KOD)
A side-by-side comparison of Immunovant, Inc. and Kodiak Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMVT
Immunovant, Inc.
$31.54HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
KOD
Kodiak Sciences Inc.
$92.88HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — IMVT vs KOD
growth of $100 · dividends reinvested · last 7yIMVT +234.2% (+18.8%/yr)KOD +3808.7% (+68.8%/yr)KOD compounded faster over this window
Log scale — wide-divergence pair
IMVT KOD
IMVT vs KOD: by the numbers
- •IMVT is the larger company ($6.51B vs $5.81B market cap).
- •Both run net losses; KOD's is the smaller (0.00% vs -7585.86% net margin).
Metrics side by side
Valuation
| Metric | IMVT | KOD |
|---|---|---|
| P/S ratio | 917.39 | N/A |
| P/B ratio | 8.85 | 95.13 |
Profitability
| Metric | IMVT | KOD |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -7585.86% | 0.00% |
| ROE | -73.19% | -396.09% |
| ROIC | -76.00% | -115.23% |
Growth (annualized)
| Metric | IMVT | KOD |
|---|---|---|
| Total return CAGR (5Y) | 29.93% | 36.19% |
Frequently asked
- How have IMVT and KOD total returns compared?
- Over the past 5 years, IMVT delivered 29.93% and KOD delivered 36.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.